Clinical TrialsSearch results
Number of results: 819
Completed
- A prospective study of investigating the efficacy of FOLFIRI plus Aflibercept as a 2nd line therapy after progression during FOLFOXIRI plus Bevacizumab in unrescetable / metastatic colorectal cancer (CRC) patients.
- Colorectal Cancer
- Oki Eiji
- 2019-04-18
Recruiting
- Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.
- colorectal cancer
- Translational Research Informatics Center(TRI)
- 2009-08-07
Other
- Randomized pahse III study evaluating the efficacy of hepatic arterial infusion chemotherapy for metastatic colorectal cancer patients with unresectable liver metastases
- Colorectal cancer
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-10
Other
- Randomized Controlled Trial to Evaluate Laparoscopic versus Open Surgery for Colorectal Cancer(JCOG 0404,CRC Surg-LAP/OPEN)
- Colorectal cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-01
Other
- Randomized control trial of follow-up schedule after curative resection for colorectal cancer
- Colorectal cancer
- Follow-up study group
- 2008-08-19
Other
- Phase III Comparative Clinical Trial of Treatment Schedules for Oral UFT/LV Therapy as Postoperative Adjuvant Chemotherapy for Stage IIB/III Colorectal Cancer
- colorectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-09-22
Other
- Phase II clinical trial of the first-line Stop-and-Go modified FOLFOX6 and bevacizmab for patients with unresectable/recurrent colorectal cancer
- colorectal cancer
- Mlnlstry of health, Labour and Welfare
- 2008-07-07
Other
- Multicenter PhaseII study of Combination FOLFIRI with Erbitux in advanced/metastatic colorectal cancer: EGFR positive and KRAS wild type
- Colorectal Cancer
- Epidemiological and Clinical Research Information Network (ECRIN)
- 2009-06-22
Other
- Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2008-11-10
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01